Literature DB >> 4086592

Fluorimetric determination of the quaternary compound trospium and its metabolite in biological material after derivatization with benoxaprofen chloride.

G Schladitz-Keil, H Spahn, E Mutschler.   

Abstract

The quantitative determination of the quaternary compound trospium and the corresponding spiroalcohol is described for human biological material. Analysis is performed by alkaline hydrolysis, ion-pair extraction into chloroform, subsequent derivatization with the flurophor benoxaprofen chloride and high-performance liquid chromatographic separation on a reversed-phase column. The limit of quantitation is ca. 1 pmol (1.03 pmol=lng of trospium chloride) per millilitre of plasma.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4086592     DOI: 10.1016/0378-4347(85)80139-0

Source DB:  PubMed          Journal:  J Chromatogr


  3 in total

Review 1.  Clinical pharmacokinetics of trospium chloride.

Authors:  Oxana Doroshyenko; Alexander Jetter; Karl P Odenthal; Uwe Fuhr
Journal:  Clin Pharmacokinet       Date:  2005       Impact factor: 6.447

Review 2.  Clinical pharmacokinetics of drugs used to treat urge incontinence.

Authors:  David R P Guay
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

3.  New Stability-Indicating RP-UFLC Method for Determination of Trospium Chloride in Tablet Dosage Form.

Authors:  Sagar Suman Panda; Bera V V Ravi Kumar; Ganeswar Mohanta; Rabisankar Dash; Pinkal Kumar Patel
Journal:  Sci Pharm       Date:  2012-08-31
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.